Market open
Oncocyte Corporation/$OCX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Oncocyte Corporation
OncoCyte Corp is a pioneering diagnostics technology company. Its mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers, or payers.
Ticker
$OCX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
48
ISIN
US68235C2061
Website
OCX Metrics
BasicAdvanced
$80M
-
-$3.35
-
-
Price and volume
Market cap
$80M
52-week high
$4.75
52-week low
$2.51
Average daily volume
44K
Financial strength
Current ratio
3.745
Quick ratio
3.57
Long term debt to equity
20.298
Total debt to equity
34.038
Interest coverage (TTM)
-238.58%
Management effectiveness
Return on assets (TTM)
-22.25%
Return on equity (TTM)
-428.96%
Valuation
Price to revenue (TTM)
12.653
Price to book
7.81
Price to tangible book (TTM)
-18.21
Price to free cash flow (TTM)
-2.066
Growth
Revenue change (TTM)
178.08%
Earnings per share change (TTM)
-31.06%
3-year revenue growth (CAGR)
38.26%
3-year earnings per share growth (CAGR)
-39.92%
OCX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Oncocyte Corporation stock?
Oncocyte Corporation (OCX) has a market cap of $80M as of May 19, 2025.
What is the P/E ratio for Oncocyte Corporation stock?
The price to earnings (P/E) ratio for Oncocyte Corporation (OCX) stock is 0 as of May 19, 2025.
Does Oncocyte Corporation stock pay dividends?
No, Oncocyte Corporation (OCX) stock does not pay dividends to its shareholders as of May 19, 2025.
When is the next Oncocyte Corporation dividend payment date?
Oncocyte Corporation (OCX) stock does not pay dividends to its shareholders.
What is the beta indicator for Oncocyte Corporation?
Oncocyte Corporation (OCX) does not currently have a Beta indicator.